Startups
TYCHON is a powerful enterprise analytics and remediation platform that provides real-time enterprise endpoint asset inventory visibility, fully automates all elements of the Department of Defense (DoD) Cyber Hygiene Scorecard (CHSC), provides Automated Continuous Endpoint Monitoring (ACEM), and delivers a flexible endpoint management query and response tool that gives administrators and incident responders complete control of their systems.
TYCHON gives operators the ability to conduct enterprise queries on a single endpoint, a range of endpoints or the entire enterprise and is engineered to provide a response to query at unprecedented speed.
Designed by seasoned incident responders and red team subject matter experts, TYCHON delivers data at higher granularity, fidelity and accuracy than other endpoint management technologies.
Built with an open framework, TYCHON easily integrates and interfaces with other 3rd party security tools as part of a defense in depth security architecture.
TYCHON gives operators the ability to conduct enterprise queries on a single endpoint, a range of endpoints or the entire enterprise and is engineered to provide a response to query at unprecedented speed.
Designed by seasoned incident responders and red team subject matter experts, TYCHON delivers data at higher granularity, fidelity and accuracy than other endpoint management technologies.
Built with an open framework, TYCHON easily integrates and interfaces with other 3rd party security tools as part of a defense in depth security architecture.
Overview
Location
United States, Minnesota, Minneapolis
Employees
11-50
Founded date
2014
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Startup’s alternative to CAR-T immunotherapy: “PAR-T” therapy | A spanking-new Minneapolis startup is building out an alternative to CAR-T immunotherapy: “PAR-T” technology. As opposed to the engineered chimeric antigen receptors used in CAR-T, Tychon Biosciences uses “prosthetic antigen receptors” to c... |
Reviews 0
FAQ about Tychon
When was Tychon founded?
Tychon was founded in 2014.
What has the press written about Tychon?
Parsers VC has collected 2 articles mentioning Tychon, among them “Startup’s alternative to CAR-T immunotherapy: “PAR-T” therapy”.
Is Tychon still active?
Yes, Tychon is active; its latest activity on Parsers VC dates from Nov 25, 2015.